Literature DB >> 20570622

Neurobiological correlates of social functioning in autism.

Emily Neuhaus1, Theodore P Beauchaine, Raphael Bernier.   

Abstract

Although autism is defined by deficits in three areas of functioning (social, communicative, and behavioral), impairments in social interest and restricted behavioral repertoires are central to the disorder. As a result, a detailed understanding of the neurobiological systems subserving social behavior may have implications for prevention, early identification, and intervention for affected families. In this paper, we review a number of potential neurobiological mechanisms--across several levels of analysis--that subserve normative social functioning. These include neural networks, neurotransmitters, and hormone systems. After describing the typical functioning of each system, we review available empirical findings specific to autism. Among the most promising potential mechanisms of social behavioral deficits in autism are those involving neural networks including the amygdala, the mesocorticolimbic dopamine system, and the oxytocin system. Particularly compelling are explanatory models that integrate mechanisms across biological systems, such as those linking dopamine and oxytocin with brain regions critical to reward processing. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20570622     DOI: 10.1016/j.cpr.2010.05.007

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  38 in total

1.  Biological pathways and genetic mechanisms involved in social functioning.

Authors:  Juan R Ordoñana; Meike Bartels; Dorret I Boomsma; David Cella; Miriam Mosing; Joao R Oliveira; Donald L Patrick; Ruut Veenhoven; Gert G Wagner; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2012-10-10       Impact factor: 4.147

2.  Autism as the Early Closure of a Neuroplastic Critical Period Normally Seen in Adolescence.

Authors:  Julia Marie Berger; Troy T Rohn; Julia Thom Oxford
Journal:  Biol Syst Open Access       Date:  2013-08-20

3.  Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity.

Authors:  Jérôme A J Becker; Daniel Clesse; Coralie Spiegelhalter; Yannick Schwab; Julie Le Merrer; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2014-03-12       Impact factor: 7.853

Review 4.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

5.  Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy.

Authors:  G Ostuzzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2014-05-01       Impact factor: 6.892

6.  Increased Expression of Kv10.2 in the Hippocampus Attenuates Valproic Acid-Induced Autism-Like Behaviors in Rats.

Authors:  Jing Wang; Shini Feng; Min Li; Yamei Liu; Jinyu Yan; Yunfei Tang; Dongshu Du; Fuxue Chen
Journal:  Neurochem Res       Date:  2019-11-15       Impact factor: 3.996

Review 7.  Epac2-mediated dendritic spine remodeling: implications for disease.

Authors:  Peter Penzes; Kevin M Woolfrey; Deepak P Srivastava
Journal:  Mol Cell Neurosci       Date:  2010-11-27       Impact factor: 4.314

Review 8.  Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention.

Authors:  Katherine K M Stavropoulos; Leslie J Carver
Journal:  J Child Psychol Psychiatry       Date:  2013-03-02       Impact factor: 8.982

9.  Postnatal maturation of GABAergic transmission in the rat basolateral amygdala.

Authors:  David E Ehrlich; Steven J Ryan; Rimi Hazra; Ji-Dong Guo; Donald G Rainnie
Journal:  J Neurophysiol       Date:  2013-05-29       Impact factor: 2.714

Review 10.  The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.

Authors:  Gerwyn Morris; Michael Berk; Andre Carvalho; Javier R Caso; Yolanda Sanz; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.